MTDR vs NBIX · P/E 14, rev $3.50B vs P/E 45, rev $2.36B
Matador Resources Company (MTDR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Matador Resources Company (MTDR) is a oil & gas e&p company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MTDR revenue for 2024-12-31 was $3.50B. Net income was $971.3M. Revenue was up 24.9% from 2023-12-31 to 2024-12-31. MTDR currently screens at market cap $6.94B and trailing P/E 14.4.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
MTDR currently screens at market cap $6.94B and trailing P/E 14.4. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the MTDR and NBIX stock pages for the full models.
Not investment advice.